Stefaan De Smedt

Stefaan De Smedt profile picture


Prof. Dr. Stefaan C. De Smedt
Pro-dean of the faculty of Pharmaceutical Sciences
Ghent Research Group on Nanomedicines
Laboratory for General Biochemistry and Physical Pharmacy
Ghent University
Ottergemsesteenweg 460
9000 Gent
Tel: 0032 9 2648047 (secretary)
Tel: 0032 9 264 8076 (direct)
Fax: 0032 9 2648189


Stefaan C. De Smedt (°1967) studied pharmacy at Ghent University (Belgium) and received his MS degree in pharmaceutical sciences in 1990. He graduated from Ghent University in 1995. In 1995 he joined the pharmaceutical development group of Janssen Research Foundation. Since 1997 he has been a post-doctoral fellow of the Flemish Fund for Scientific Research at the Departments of Pharmacy of respectively Ghent University and the University of Utrecht (the Netherlands). In October 1999 he became Professor in Physical Pharmacy and Biopharmacy at Ghent University where he founded the Ghent Research Group on Nanomedicines. In 2007 Stefaan C. De Smedt was guest professor at the Catholic University of Leuven (Belgium), from 2012 till 2014 he was appointed guest professor at the University of Antwerp (Belgium). He served as dean of the Faculty of Pharmaceutical Sciences at Ghent University from 2010 till 2014. Since 2014 he is a member of the Board of Directors of Ghent University and is fully involved in the Ghent Research Group on Nanomedicines.

Dr. S.C. De Smedt received the Scott Blair Biorheology Award for his Ph.D work; For his research on drug delivery he received the Controlled Release Society Young Investigator Award 2006 and the APV Research Award 2010 for Outstanding Research Achievements in Pharmaceutical Sciences.

Dr. S.C. De Smedt is/has been a member of a number of Belgian and (non-)European scientific expert panels, like the panel of ‘pharmaceutical sciences and protein chemistry’ of the Flemish Fund for Scientific Research (FWO), the panel of US-Israel Binational Science Foundation, the panel of Health and Health Services Research Fund of Hong Kong, the expert panel of the Academy of Finland, the expert panel of the Agence Nationale de la Recherche (France). Since 2012 he is one of the key organizers of the (bi-annual) European Symposium of Controlled Drug Delivery which takes place in the Netherlands every other year ( Since 2004 Dr. De Smedt serves as the European Associate Editor of the Journal of Controlled Release (; In 2015 he became Editor of JCR (for the region Europe- the Middle East & Africa)

Recent research interest of Professor De Smedt have included micro- and nanomaterials for (especially) drug delivery and diagnostics. His research is at the interface between drug delivery, biophysics, material sciences and advanced optical imaging. Dr. Stefaan De Smedt holds patents on carriers for drug delivery and diagnostics. He is a scientific founder of Memobead Technologies, a spin-off from Ghent University, whose technology is currently under further development by Biocartis in Lausanne (Swiss) and Mechelen (Belgium). Dr. De Smedt is a member of the Drug Delivery Advisory Panel of Santen Pharmaceutical specialized in ophthalmic pharmaceuticals.